Blog
Our Perspectives
Latest
Decision Debt: The Cost Clinical Development Doesn't Track
Date
June 11, 2026
.png)
Topics
- machine-learning
- digital-twins
- digital-twin-generators
- regulatory
- twinrcts
- unlearn-ing
Disease
- alzheimers-disease
- amyotrophic-lateral-sclerosis
- asthma
- atopic-dermatitis
- copd
- coronary-artery-disease
- crohns-disease
- dyslipidemia
- frontotemporal-dementia
- huntingtons-disease
- hypertension
- migraine
- obesity
- osteoarthritis
- osteoporosis
- parkinsons-disease
- psoriasis
- psoriatic-arthritis
- rheumatoid-arthritis
- sci
- stroke
- type-2-diabetes
- ulcerative-colitis
Date
- 2022
- 2023
- 2024
- 2025
- 2026
.png)
The Best 15 Minutes You’ll Spend on Clinical Trials Today
Date
June 24, 2025
How Unlearn Boosts Trial Power Using the FDA’s AI Framework
Date
June 18, 2025
How we’re helping biotechs like ProJenX run smarter ALS trials
Date
May 16, 2025
Unlocking Smarter Parkinson’s Disease Trials with Digital Twins
Date
April 30, 2025
Smarter Endpoints, Stronger Trials: How AI-Optimized Measures Are Advancing Neurodegenerative Disease Research
Date
February 13, 2025
Why the FDA’s New AI Guidelines Matter for Clinical Research
Date
January 9, 2025
Why Unlearn and APST’s Partnership Matters for ALS Innovation
Date
December 5, 2024
Supporting Every Stakeholder in Clinical Trials with AI-Powered Digital Twins
Date
November 7, 2024
Unlearn’s Next Chapter: Scaling AI in Healthcare
Date
September 25, 2024
3 / 8